AI giant Anthropic confidentially files for US IPO as investors bet big on AI future

Anthropic has confidentially filed for a U.S. IPO after last raising $65 billion at a $965 billion post-money valuation in late May, setting up one of the largest potential listings in years. The move underscores continued investor appetite for AI leaders and could reshape IPO market flows, though a debut of this size may crowd out smaller offerings and draw liquidity toward mega-cap AI names.

Analysis

This is less about one private company and more about the public-market repricing of AI capex intensity. If a near-$1T private valuation can clear the IPO gate, it strengthens the premium on the entire compute stack: model enablers, inference infrastructure, and the hardware names that monetize the race to scale. The second-order effect is that public investors may rotate from software-disruption shorts back into picks-and-shovels beneficiaries, because the fastest way to capture AI demand without single-company execution risk is still through infrastructure-linked equities.

SMCI and APP are the cleanest liquid expressions of that trade, but for different reasons. SMCI benefits if the market reads this as another validation of rack-scale buildout and incremental server demand; however, its multiple is far more vulnerable to any deceleration in hyperscaler capex, so it trades better as a momentum vehicle than a fundamental compounder. APP’s exposure is more indirect but important: when AI capital raises and IPOs dominate the tape, adtech and app-discovery platforms can benefit from improved risk appetite and broader tech beta, though that support fades quickly if the market starts distinguishing winners from speculative story stocks.

The key risk is timing mismatch: IPO headlines are immediate, but monetization and index inclusion are months away. That means the first move is likely a sentiment trade, while the larger move depends on whether new listings absorb capital that would otherwise support existing AI names; if so, some recent leaders could underperform even as the theme stays hot. A sharp reversal would come from either a weak IPO book or a broader de-rating of long-duration growth if rates back up, because the market is currently paying for future optionality, not current cash flow.

The contrarian read is that the market may be underestimating crowding. A marquee listing can catalyze enthusiasm, but it also creates a benchmark that forces investors to reassess every private AI name against an almost absurd private-market reference point; that can actually compress returns elsewhere if public comps are no longer viewed as scarce. In that scenario, the trade is not to chase every AI proxy, but to own the most obvious infrastructure beneficiaries while fading the most expensive software exposures that rely on perpetual narrative support.

Key Decisions for Investors

• Go long SMCI on a momentum basis into the IPO window; use a 4-8 week horizon and treat it as a sentiment trade, with a tight stop if AI hardware sentiment rolls over or hyperscaler capex commentary softens.
• Buy APP on dips as a secondary AI-risk-on beneficiary; 1-3 month horizon, lower direct AI beta than SMCI, but likely to outperform if tech multiples broaden rather than narrow.
• Pair trade: long SMCI / short a basket of expensive AI-software names with no clear monetization path; thesis is that capital rotates toward tangible picks-and-shovels as private-market AI headlines intensify.
• For option traders, use call spreads rather than outright calls in SMCI to reduce valuation risk; the setup favors a sharp move, but upside is vulnerable to any weak IPO pricing or broader growth multiple compression.
• Avoid chasing every AI-related name into the IPO headlines; wait for the first post-announcement reversal day before adding exposure, since the near-term trade is likely crowded and vulnerable to a liquidity air-pocket.